RGC logo

Regencell Bioscience Holdings Limited

RGC
Healthcare|Drug Manufacturers - Specialty & Generic|HK
$5.27
+0.00 (+0.00%)
DCF Value
$0.03
Tangible Book / Share
$0.03
Cash / Share
$0.03
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest May 19, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

RGC Resources, Inc. Declares Quarterly Dividend
Sep 28, 2026 · GlobeNewsWire

SEC Filings (20)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 7, 202620-FAnnual report (foreign)DocumentIndex
May 22, 20266-KForeign issuer reportDocumentIndex
May 19, 2026424B5Offering prospectusDocumentIndex
May 19, 20266-KForeign issuer reportDocumentIndex
May 19, 20266-KForeign issuer reportDocumentIndex
May 8, 20266-KForeign issuer reportDocumentIndex
Apr 17, 20266-KForeign issuer reportDocumentIndex
Mar 30, 20266-KForeign issuer reportDocumentIndex
Mar 30, 20266-KForeign issuer reportDocumentIndex
Mar 30, 2026424B5Offering prospectusDocumentIndex
Mar 30, 2026F-3ASRShelf registrationDocumentIndex
Feb 13, 20266-KForeign issuer reportDocumentIndex
Oct 31, 202520-FAnnual report (foreign)DocumentIndex
Jul 11, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 30, 20256-KForeign issuer reportDocumentIndex
Jun 30, 20256-KForeign issuer reportDocumentIndex
Jun 17, 20256-KForeign issuer reportDocumentIndex
Jun 2, 20256-KForeign issuer reportDocumentIndex
Mar 13, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Jan 15, 20256-KForeign issuer reportDocumentIndex